Impact Of Uraemic Xerosis And Pruritus On Quality Of Life Among Maintenance Hemodialysis Patients
DOI:
https://doi.org/10.52783/jns.v14.3018Keywords:
Uraemic xerosis, Uraemic pruritus, Quality of life, Maintenance hemodialysis, End stage renal diseaseAbstract
Background: ESRD (end-stage renal disease) is a substantial public health problem, and people endure a vast variety of its symptoms. Uraemic xerosis and pruritus are symptoms in CKD (chronic kidney disease) patients, significantly impairing quality of life. Furthermore, it is an independent risk factor for poorer survival rates. The aim of this study was to evaluate the impact of uraemic xerosis and pruritus on patients' quality of life.
Materials and methods: Over the course of six months, 100 hemodialysis patients were chosen for a descriptive, cross-sectional study that was carried out in the hemodialysis unit of ACS Medical College and Hospital. Patients who had prurigo, superficial infections, contact dermatitis, AKI patients, or who were not receiving dialysis for chronic kidney disease were excluded from the study, and the patients were asked to provide informed consent. The EL Gammal severity score, VAS (100mm visual analogue scale), DLQI (Dermatology life quality index), and SF-12 (12-item short form survey) were used to evaluate the intensity of xerosis, pruritus, and quality of life, respectively.
Results: Using the generic SF-12 questionnaire, it was shown that hemodialysis patients with end-stage renal disease had a markedly altered quality of life, with reductions observed on both the physical (mean ±SD PCS: 30.60 ± 6.959) and mental (mean ±SD MCS: 28.72 +10.197) components. In our investigation, we found a weak but statistically significant association (p=0.073) between DLQI and the intensity of xerosis and a substantial correlation (p=0.000) between DLQI and pruritus. According to an analysis of demographic characteristics on DLQI and lesional status. Elderly patients also experience a severe deterioration in their quality of life (0.000*).
Conclusion: It was determined that maintenance hemodialysis patients' quality of life is negatively impacted by uraemic xerosis and pruritus. Older age was also an aggravating factor for the deterioration of the quality of life.
Downloads
Metrics
References
Anderson S, Halter JB, Hazzard WR, et al.: Prediction, progression, and outcomes of chronic kidney disease in older adults. J Am Soc Nephrol. 2009, 20:1199-1209. 10.1681/ASN.2008080860
Ojo A: Addressing the global burden of chronic kidney disease through clinical and translational research. Trans Am Clin Climatol Assoc. 2014, 125:229-243.
Senanayake S, Gunawardena N, Palihawadana P, Bandara P, Haniffa R, Karunarathna R, Kumara P: Symptom burden in chronic kidney disease; a population based cross sectional study BMC Nephrol. 2017, 18:228. 10.1186/s12882-017-0638-y
Dąbrowska-Bender M, Dykowska G, Żuk W, Milewska M, Staniszewska A: The impact on quality of life of dialysis patients with renal insufficiency. Patient Prefer Adherence. 2018, 12:577-583. 10.2147/PPA.S156356
Valderrabano F, Jofre R, Lopez-Gomez JM: Quality of life in end-stage renal disease patients. Am J Kidney Dis. 2001, 38:443-464. 10.1053/ajkd.2001.26824
Bencini PL, Montagnino G, Citterio A, Granziani G, Crosti C, Ponticelli C. Cutaneous abnormalities in uraemic patients. Nephron 1985; 40: 316-321
Parfrey PS, Vavasour HM, Henry S, Bullock M, Gault MH. Clinical features and severity of nonspecific symptoms in dialysis patients. Nephron 1988; 50: 121-128
Ponticelli C, Bencini PL. Uremic pruritus: A review. Nephron 1992; 60: 1-5
Stahle-Backdahl M. Uremic pruritus: clinical and experimental studies. Ada Derm Venereol(Stockh) 1989; 145 [Suppl]: 1-38
I. Narita, S. Iguchi, K. Omori, and F. Gejyo, “Uremic pruritus in chronic hemodialysis patients,” Journal of Nephrology, vol. 21, no. 2, pp. 161–165, 2008.
Kfoury LW, Jurdi MA: Uremic pruritus. J Nephrol. 2012, 25:644-52.
Chodorowska G, Wysokiński A, Chodorowski J: Uremic pruritus in the chronic renal failure patients. Ann Univ Mariae Curie Sklodowska Med. 2004, 59:174-9.
Suseł J, Batycka-Baran A, Reich A, Szepietowski JC: Uraemic pruritus markedly affects the quality of life and depressive symptoms in haemodialysis patients with end-stage renal disease. Acta Derm Venereol. 2014, 94:276-81. 10.2340/00015555-1749
El Gammal C, Pagnoni A, Kligman AM, El Gammal S. A model to assess the efficacy of moisturizers – the quantification of soap-induced xerosis by image analysis of adhesive-coated discs (D-squames®). Clin Exp Dermatol 1996; 21: 338–343.
Both H, Essink-Bot ML, Busschbach J, Nijsten T. Critical review of generic and dermatology-specific health-related quality of life instruments. J Invest Dermatol 2007; 127: 2726–2739.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210–216.
Zucker I, Yosipovitch G, David M, Gafter U, Boner G. Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease. J Am Acad Dermatol 2003; 49: 842–846.
Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: What do dermatology life quality index scores mean? J Invest Dermatol 2005; 125: 659–664.
Balaskas EV, Chu M, Uldall RP, Gupta A, Oreopoulos DG. Pruritus in continuous ambulatory peritoneal dialysis and haemodialysis patients. Perit Dial Int 1992; 13: S527– S532.
Szepietowski JC, Sikora M, Kusztal M, Salomon J, Magott M, Szepietowski T. Uremic pruritus: a clinical study of maintenance hemodialysis patients. J Dermatol 2002; 29: 621–627.
Young AW Jr, Sweeney EW, David DS, Cheigh J, Hochgelerent EL, Sakai S, et al. Dermatologic evaluation of pruritus in patients on hemodialysis. NY State J Med 1973; 73: 2670–2674.
Nielsen T, Hemmeloff-Andersen KE, Kristiansen J. Pruritus and xerosis in patients with chronic renal failure. Dan Med Bull 1980; 27: 269–271.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
